First Issue of New HFSA Journal of Cardiac Failure-Intersections

The first issue of the Journal of Cardiac Failure-Intersections, an open-access journal focused on heart failure and its many intersections, is now available.

WASHINGTON, Sept. 17, 2025 /PRNewswire/ -- Scientific breakthroughs often begin with a single Aha! Moment—an idea that evolves into a hypothesis and is then rigorously tested. In that spirit, we are proud to introduce the inaugural issue of the Journal of Cardiac Failure-Intersections, bringing this bold approach to the heart of our new journal initiative.

In a landscape saturated with biomedical publications—and at a time when the relevance of traditional journals is being reexamined—we believe that a journal driven by innovation, transformation, and interdisciplinary collaboration can not only thrive but inspire a new generation of scientific dialogue. What sets our journal apart is a commitment to breaking traditional boundaries—fostering meaningful intersections across disciplines and bringing together diverse voices in medicine. The Journal of Cardiac Failure–Intersections embodies this vision, focusing on heart failure and its critical connections across the broader cardiovascular community.

"Historically some of the most powerful innovations have occurred at the intersections of life, and I anticipate the Journal of Cardiac Failure-Intersections will fully embrace this concept – whether it be at the intersection of heart failure with other subspecialties, health policy, the environment, ethics, entrepreneurship, the humanities, well-being, or something entirely unexpected," noted Editor-in-Chief Jason N. Katz MD, MHS.

Guided by Jazon N, Katz, MD, MHS, Editor-in-Chief, Nosheen Reza, MD, MS, Deputy Editor and a distinguished Editorial Board composed of leading experts across diverse specialties within all areas of medicine, the first issue features a sampling of the types of papers the journal will be publishing.

The lead paper is a post-hoc analysis of the Role of Rhythm Control with Antiarrhythmic Agents in Heart Failure with Preserved Ejection Fraction: Insights from the AFFIRM Trial. This article evaluates how controlling heart rhythm with certain medications may increase the risk of mortality among HFpEF patients who were randomized to rhythm control rather than rate control using drug therapy.

Also highlighted in the issue is a Patient Perspectives on Genetic Testing in Transthyretin Amyloid Cardiomyopathy, which found 4 common themes that will help inform implementation strategies around cardiomyopathy-related genetic testing. While a Research Letter, Perceptions of Gender Diversity and Discrimination Against Physicians in Advanced Heart Failure and Transplant Cardiology, explores the representation of women and racially/ethnically diverse groups in cardiology.

"On behalf of the Heart Failure Society Board of Directors, we are excited to share with our heart failure community the inaugural issue of the Journal of Cardiac Failure-Intersections. Rarely do we see heart failure in isolation, and with this new offering from the JCF Family of Journals, we can better illustrate all the ways heart failure intersects with the larger medical community. We hope you find this first historic issue of interest and look forward to many more years of intersections with our community," said Michael Felker, MD, 2024-2025 HFSA President.

JCF-Intersections serves as a platform for discussion, connection, and education. The journal focuses on strengthening research at the intersection of heart failure and other fields, including ethics, technology & entrepreneurship, oncology, prevention, humanities, policy & law, obstetrics, critical care, and more, to cultivate uncommon partnerships, novel viewpoints, and agile teams that influence the care of our patients, families, and communities.

.The full line-up for the Journal of Cardiac Failure-Intersections Inaugural issue is as follows:

Original Research Papers

• Role of Rhythm Control with Antiarrhythmic Agents in Heart Failure with Preserved Ejection Fraction: Insights from the AFFIRM Trial
  • Editorial: Navigating the Intersections: Re-evaluating Rhythm Control in Atrial Fibrillation and Heart Failure with Preserved Ejection Fraction
• Patient Perspectives on Genetic Testing in Transthyretin Amyloid Cardiomyopathy: Framing the Conversation to Improve Implementation
  • Editorial: Bridge the Gap: Genetic Testing in Transthyretin Amyloidosis
• Clinical Impacts of High Intensity Care in the Cardiac Intensive Care Unit: systematic review and meta-analysis
  • Editorial: High Intensity Staffing: An essential component to the delivery of modern CICU care
• Hospitalization Outcomes in the AHA Get With The Guidelines Atrial Fibrillation and Heart Failure Registries
  • o Editorial: Getting with the Guidelines: Improving Quality of Hospital Care in Atrial Fibrillation and Heart Failure
• Females on Veno-Arterial Extracorporeal Membrane Oxygenation: A Comparative Analysis
  • Editorial: Sex Differences in Patients with Cardiogenic Shock Supported with Veno-arterial ECMO: Defining and Addressing the Persistent Gap

State-of-the-Art Review

• The Training Program as a Catalyst for Clinical Trials in Cardiac Critical Care: The DOREMI Experience

Perspectives

• Cardiovascular-Kidney-Metabolic Syndrome: A Paradigm for Value-Based Care

Research Letter

• Perceptions of Gender Diversity and Discrimination Against Physicians in Advanced Heart Failure and Transplant Cardiology

View the full issue online. For interviews with authors, please contact Laura Poko at [email protected].  

About the Journal of Cardiac Failure-Intersections

The Journal of Cardiac Failure-Intersections is an open-access journal with a focus on heart failure and its various intersections with other disciplines and specialties within the broader cardiovascular community. The journal has a special focus on how multidisciplinary partnerships impact patient care. Published papers will span original investigator-initiated work to state-of-the-art reviews, expert perspectives, including those with a global viewpoint, early career and trainee spotlight pieces, and patient and patient-partner narratives.  

About the Heart Failure Society of America

The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers, and patients. For more information, visit hfsa.org.

Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected] 

SOURCE Heart Failure Society of America